{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T20:57:38Z","timestamp":1762808258758,"version":"3.40.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-0711-13-12","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T14:03:07Z","timestamp":1395842587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis"],"prefix":"10.1186","volume":"13","author":[{"given":"Mahmut","family":"Sunnetcioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafer","family":"Mengeloglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Irfan","family":"Baran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Karahocagil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Tosun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir","family":"Kucukbayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Resat","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayrettin","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cenk","family":"Aypak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,26]]},"reference":[{"key":"323_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2133.1997.tb08740.x","volume":"136","author":"A Rowe","year":"1997","unstructured":"Rowe A, Farrell AM, Buncer CB: Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997, 136: 18-23. 10.1111\/j.1365-2133.1997.tb08740.x","journal-title":"Br J Dermatol"},{"key":"323_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43: 109-134.","journal-title":"Pharmacol Rev"},{"key":"323_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/cc5076","volume":"10","author":"RH B\u00f6ger","year":"2006","unstructured":"B\u00f6ger RH: Live and let die: asymmetric dimethylarginine and septic shock. Crit Care 2006, 10: 169. 10.1186\/cc5076","journal-title":"Crit Care"},{"key":"323_CR4","first-page":"455","volume":"43","author":"M Tosun","year":"2013","unstructured":"Tosun M, Apuhan T: Asymmetric dimethylarginine levels in allergic rhinitis and nasal polyposis. Turkish J Med Sci 2013, 43: 455-458.","journal-title":"Turkish J Med Sci"},{"key":"323_CR5","first-page":"295","volume":"2002","author":"R Brookmeyer","year":"1861","unstructured":"Brookmeyer R, Blades N: Prevention of inhalational anthrax in the U. S. outbreak. Science 1861, 2002: 295.","journal-title":"Science"},{"key":"323_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/S0002-9440(10)63548-1","volume":"163","author":"WJ Shieh","year":"2003","unstructured":"Shieh WJ, Guarner J, Paddock C, Greer P, Tatti K, Fischer M, Layton M, Philips M, Bresnitz E, Quinn CP, Popovic T, Perkins BA, Zaki SR, Anthrax Bioterrorism Investigation Team: Anthrax Bioterrorism Investigation Team. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol 2003, 163: 1901-1910. 10.1016\/S0002-9440(10)63548-1","journal-title":"Am J Pathol"},{"key":"323_CR7","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/clinids\/19.6.1009","volume":"19","author":"FM LaForce","year":"1994","unstructured":"LaForce FM: Anthrax. Clin Infect Dis 1994, 19: 1009-1013. 10.1093\/clinids\/19.6.1009","journal-title":"Clin Infect Dis"},{"key":"323_CR8","first-page":"105","volume":"33","author":"H Miyazaki","year":"1999","unstructured":"Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T: Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999, 33: 105-106.","journal-title":"Circulation"},{"key":"323_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0735-1097(01)01318-3","volume":"38","author":"P Lundman","year":"2001","unstructured":"Lundman P, Eriksson MJ, Stuhlinger M, Cooke JP, Hamsten A, Tornvall P: Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 2001, 38: 111-116. 10.1016\/S0735-1097(01)01318-3","journal-title":"J Am Coll Cardiol"},{"key":"323_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/cc1864","volume":"7","author":"B Vallet","year":"2003","unstructured":"Vallet B: Bench-to-bed side review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care 2003, 7: 130-138. 10.1186\/cc1864","journal-title":"Crit Care"},{"key":"323_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/cc5053","volume":"10","author":"MJ O\u2019Dwyer","year":"2006","unstructured":"O\u2019Dwyer MJ, Dempsey F, Crowley V, Kelleher DP, McManus R, Ryan T: Septic shock is correlated with asymmetrical dimetyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit Care 2006, 10: 139. 10.1186\/cc4898","journal-title":"Crit Care"},{"key":"323_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.phrs.2009.05.002","volume":"60","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamagishi S: Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock. Pharmacol Res 2009, 60: 515-518. 10.1016\/j.phrs.2009.05.002","journal-title":"Pharmacol Res"},{"key":"323_CR13","first-page":"325","volume":"76","author":"G Iapichino","year":"2010","unstructured":"Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R: Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Minerva Anestesiol 2010, 76: 325-333.","journal-title":"Minerva Anestesiol"},{"key":"323_CR14","first-page":"235","volume":"57","author":"H Irmak","year":"2003","unstructured":"Irmak H, Buzgan T, Karahocagil MK, Sakarya N, Akdeniz H, Caksen H, Demir\u00f6z P: Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases. Acta Med Okayama 2003, 57: 235-240.","journal-title":"Acta Med Okayama"},{"key":"323_CR15","first-page":"449","volume":"36","author":"M Sahin","year":"2006","unstructured":"Sahin M, Arslan C, Naziroglu M, Tunc SE, Demirci M, Sutcu R, Yilmaz N: Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet\u2019s disease. Ann Clin Lab Sci 2006, 36: 449-454.","journal-title":"Ann Clin Lab Sci"},{"key":"323_CR16","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0002-9440(10)62496-0","volume":"166","author":"JM Warfel","year":"2005","unstructured":"Warfel JM, Steele AD, D'Agnillo F: Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol 2005, 166: 1871-1881. 10.1016\/S0002-9440(10)62496-0","journal-title":"Am J Pathol"},{"key":"323_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-2672.1999.00867.x","volume":"87","author":"M Hugh-Jones","year":"1999","unstructured":"Hugh-Jones M: 1996\u201397 Global Anthrax Report. J Appl Microbiol 1999, 87: 189-191. 10.1046\/j.1365-2672.1999.00867.x","journal-title":"J Appl Microbiol"},{"key":"323_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3201\/eid0810.020353","volume":"8","author":"DB Jernigan","year":"2002","unstructured":"Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer M, Greene C, Griffith KS, Guarner J, Hadler JL, Hayslett JA, Meyer R, Petersen LR, Phillips M, Pinner R, Popovic T, Quinn CP, Reefhuis J, Reissman D, Rosenstein N, Schuchat A, Shieh WJ, Siegal L, Swerdlow DL, Tenover FC, Traeger M, et al.: Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002, 8: 1019-1028. 10.3201\/eid0810.020353","journal-title":"Emerg Infect Dis"},{"key":"323_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.phrs.2009.07.009","volume":"60","author":"K Kurz","year":"2009","unstructured":"Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D: Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers. Pharmacol Res 2009, 60: 508-514. 10.1016\/j.phrs.2009.07.009","journal-title":"Pharmacol Res"},{"key":"323_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3851\/IMP2304","volume":"17","author":"K Kurz","year":"2012","unstructured":"Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D: Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy. Antivir Ther 2012, 17: 1021-1027. 10.3851\/IMP2304","journal-title":"Antivir Ther"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-0711-13-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:53:21Z","timestamp":1746161601000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/1476-0711-13-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,26]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1186\/1476-0711-13-12","relation":{},"ISSN":["1476-0711"],"issn-type":[{"type":"electronic","value":"1476-0711"}],"subject":[],"published":{"date-parts":[[2014,3,26]]},"assertion":[{"value":"31 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}